Skip to main content
Clinical Trials/NCT06643832
NCT06643832
Completed
Not Applicable

Spinal and Supra-spinal Modulation of Propofol Injection Pain by Rubbing and Distraction: A Randomized Controlled Study

Tanta University1 site in 1 country135 target enrollmentOctober 16, 2024

Overview

Phase
Not Applicable
Intervention
Rubbing Distraction
Conditions
Propofol Injection
Sponsor
Tanta University
Enrollment
135
Locations
1
Primary Endpoint
Incidence of propofol injection pain
Status
Completed
Last Updated
last year

Overview

Brief Summary

This prospective randomized controlled study will be conducted to evaluate the effects of rubbing and distraction on the incidence and severity of propofol injection pain and compare them with the standard intravenous lidocaine method.

Detailed Description

Propofol has become one of the most common anesthetic agents used for sedation, induction, and maintenance of anesthesia because of its unique pharmacological properties. Pain during bolus injection is a major drawback with an incidence as high as 80%-90% in an untreated patient. One of the most effective factors that alleviate the injection pain involves pretreatment with lidocaine. Spinal modulation of pain is explained by the melzack gate control theory, it proposed that stimulation of A beta fibers by touch and vibration, modulate the dorsal horn "gate" and therefore the nociceptive input from the periphery could be reduced. (5) Regarding the use of this concept for managing propofol pain, only one study was conducted and revealed that rubbing didn't decrease the incidence but significantly decreased the severity of pain. Distraction is a method of removing attention; so, it modifies cognitive pain perceptions by altering nociceptive responses and triggering an internal pain-suppressing system. Therefore, it causes a decrease in the activation of areas in the brain (e.g.: thalamus and insula) which contribute significantly to pain perception. we will combine rubbing and distraction, as methods for spinal and supra-spinal pain modulation, to evaluate their effects on propofol injection pain and compare them with the standard intravenous lidocaine method.

Registry
clinicaltrials.gov
Start Date
October 16, 2024
End Date
February 17, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Osama Rehab

Lecturer of anesthesiology, surgical Intensive care and pain medicine

Tanta University

Eligibility Criteria

Inclusion Criteria

  • Patients of either sex
  • American Society Anesthesiologists physical (ASA) status I-II
  • age between 18-65 years old
  • undergoing elective surgeries under general anesthesia using Propofol for anesthetic induction.

Exclusion Criteria

  • Allergy to experimental drugs
  • Abuse of alcohol, analgesia, or sedative antidepressant
  • Difficulty in communication
  • Chronic pain syndromes, thrombophlebitis, neurological disease, and analgesic administration at the time of the study

Arms & Interventions

Rubbing Distraction group

rubbing and gently touching on proximal part of the intravenous injection site with the palm of the hand extending to the elbow. This will be started 5 seconds before propofol injection (not mixed with any drug) and continued until loss of consciousness. Also, a mobile video with duration of 10 seconds will be used for distraction and will be started 5 seconds before propofol injection so as to be ended at the time of first pain assessment.

Intervention: Rubbing Distraction

Lidocaine group

patients will receive intravenous propofol mixed with 2ml of lidocaine 2% (40mg) before injection.

Intervention: Lidocaine (drug)

Saline group

patients will receive intravenous propofol not mixed with any drug (except for 2 ml of saline to ensure blindness of the outcome assessor).

Intervention: Saline

Outcomes

Primary Outcomes

Incidence of propofol injection pain

Time Frame: Pain will be evaluated every 5 seconds during the propofol injection until loss of concioussness. The highest pain score will be recorded

Pain will be graded using a four-point scale: 0 = no pain, 1 = mild pain (pain reported only in response to questioning without any behavioral signs), 2 = moderate pain (pain reported in response to questioning and accompanied by a behavioral sign or pain reported spontaneously without questioning), and 3 = severe pain (i.e., strong vocal response or response accompanied by facial grimacing, arm withdrawal, or tears).

Secondary Outcomes

  • Degree of pain(every 5 seconds during injection and the highest value will be recorded.)
  • Recall of pain(1 hour after surgery)
  • adverse effects(1 hour after surgery)

Study Sites (1)

Loading locations...

Similar Trials